A Study to Assess the Effects of BMS-986371 on the Drug Levels of Methotrexate in the Presence and Absence of Sulfasalazine
Clinical trial NCT05445440 · COMPLETED
Trial details
- NCT number
- NCT05445440
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2022-11-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.